CF PharmTech (HKG:2652) is partnering with JD Health International (HKG:6618) to launch a number of respiratory and rhinology therapeutic products, according to a Hong Kong bourse filing Monday.
The firm said JD Health will serve as the exclusive online launch platform for a number of products over the next three years.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.